World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
118
Citations
51962
World Ranking
4056
National Ranking
2221

Overview

Zeev Estrov is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily concentrates in the field of medicine, with a significant focus on hematology, genetics, molecular biology, immunology, and rheumatology. The subfield hematology accounts for the largest portion of their work.

The main topics covered in Estrov's research include:

  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research
  • Eosinophilic Disorders and Syndromes
  • Acute Lymphoblastic Leukemia research
  • Lymphoma Diagnosis and Treatment

Estrov has contributed to 225 medical publications, with hematology featuring prominently through 84 publications. Genetics and molecular biology fields also mark significant research activity. Their frequent publication venues include:

  • Blood (41 publications)
  • Clinical Lymphoma Myeloma & Leukemia (15 publications)
  • Leukemia (7 publications)
  • Cancer (7 publications)
  • American Journal of Hematology (5 publications)

Recent peer-reviewed papers involving or related to their work cover topics related to leukemias and antifungal prophylaxis, such as:

  • 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial (2020, The Lancet Haematology)
  • Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia (2021, JAMA Oncology)
  • Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study (2020, Clinical Infectious Diseases)
  • A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia (2020, Leukemia)
  • A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome (2021, Haematologica)

They frequently collaborate with other researchers, including:

  • Hagop M. Kantarjian
  • Naveen Pemmaraju
  • Srđan Verstovšek
  • Prithviraj Bose
  • Tapan M. Kadia

Best Publications

  • The biology of chronic myeloid leukemia

    Stefan Faderl;Moshe Talpaz;Zeev Estrov;Susan O'Brien

  • Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis

    Srdan Verstovsek;Hagop Kantarjian;Ruben A. Mesa;Animesh D. Pardanani

  • Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia

    Marina Konopleva;Rooha Contractor;Twee Tsao;Ismael Samudio

  • Adult stem cells for tissue repair - a new therapeutic concept?

    Martin Körbling;Zeev Estrov

  • Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells.

    Martin Körbling;Ruth L. Katz;Abha Khanna;Arnout C. Ruifrok

  • Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes

    Alvaro Aguayo;Hagop M Kantarjian;Taghi Manshouri;Cristi Gidel

  • Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia

    Hagop Kantarjian;Yasuhiro Oki;Guillermo Garcia-Manero;Xuelin Huang

  • Chronic Myelogenous Leukemia: Biology and Therapy

    Stefan Faderl;Moshe Talpaz;Zeev Estrov;Hagop M. Kantarjian

  • Chronic myelogenous leukemia: a concise update

    H. M. Kantarjian;A. Deisseroth;R. Kurzrock;Z. Estrov

  • Transdifferentiation of Human Peripheral Blood CD34+-Enriched Cell Population Into Cardiomyocytes, Endothelial Cells, and Smooth Muscle Cells In Vivo

    Edward T.H. Yeh;Sui Zhang;Henry D. Wu;Martin Körbling

  • Phase 1/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemia.

    Guillermo Garcia-Manero;Hagop M. Kantarjian;Blanca Sanchez-Gonzalez;Hui Yang

  • Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome

    Andres O. Soriano;Hui Yang;Stefan Faderl;Zeev Estrov

  • Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia.

    Alessandra Ferrajoli;Bang-Ning Lee;Ellen J. Schlette;Susan M. O'Brien

  • Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia.

    Alvaro Aguayo;Elihu Estey;Elihu Estey;Hagop M Kantarjian;Hagop M Kantarjian;Taghi Mansouri;Taghi Mansouri

  • Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells.

    Michael Sun;Zeev Estrov;Yuan Ji;Kevin R. Coombes

  • Ibrutinib and venetoclax for first-line treatment of CLL

    Nitin Jain;Michael Keating;Philip Thompson;Alessandra Ferrajoli

  • Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance

    Antonina V. Kurtova;Kumudha Balakrishnan;Rong Chen;Wei Ding

  • Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera

    Alfonso Quintás-Cardama;Hagop Kantarjian;Taghi Manshouri;Rajyalakshmi Luthra

  • Phase I/II Study of Combination Therapy With Sorafenib, Idarubicin, and Cytarabine in Younger Patients With Acute Myeloid Leukemia

    Farhad Ravandi;Jorge E Cortes;Daniel Jones;Stefan H Faderl

  • Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia.

    Stefan Faderl;Hagop M. Kantarjian;Moshe Talpaz;Zeev Estrov

Frequent Co-Authors

Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Jorge E. Cortes
Jorge E. Cortes Augusta University
Guillermo Garcia-Manero
Guillermo Garcia-Manero The University of Texas MD Anderson Cancer Center
Susan O'Brien
Susan O'Brien University of California, Irvine
Farhad Ravandi
Farhad Ravandi The University of Texas MD Anderson Cancer Center
Alessandra Ferrajoli
Alessandra Ferrajoli The University of Texas MD Anderson Cancer Center
William G. Wierda
William G. Wierda The University of Texas MD Anderson Cancer Center
Gautam Borthakur
Gautam Borthakur The University of Texas MD Anderson Cancer Center
Elias Jabbour
Elias Jabbour The University of Texas MD Anderson Cancer Center
Srdan Verstovsek
Srdan Verstovsek The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering alternative or related pathways to studying Medicine in the USA? Many students interested in healthcare careers look at nursing degrees, which offer flexible entry options and a variety of roles. Online education has expanded these opportunities, allowing students to balance study and work, or switch fields more easily.

For those seeking advanced qualifications, online nursing doctoral programs provide a path to leadership and research roles. If you're already an RN, exploring the average cost of rn to bsn programs can help you plan for the next step in your career.

Non-nurses looking to enter the profession quickly can consider an online direct entry msn, designed for those with a bachelor’s degree in another field. Additionally, some institutions offer direct admit nursing programs, making the process more accessible for new students.

Exploring these online degrees and career pathways can provide a flexible, cost-effective, and rewarding way to join the healthcare sector in the USA.

Best Scientists Citing Zeev Estrov

Trending Scientists